Contact – +1-276-477-5910
 Email –

Home >> Publisher >>



Global Bioresorbable Stents Market By Type of materials (polymer based and metal based), Rate of Absorption (Fast and Slow), Application (Coronary Artery, Peripheral Artery), End-user (Hospitals and Cardiac centers and patients)-Global Market Trends & Industry Forecasts Upto 2023...

Global Bioresorbable Stents Market By Type of materials (polymer based and metal based), Rate of Absorption (Fast and Slow), Application (Coronary Artery, Peripheral Artery), End-user (Hospitals and Cardiac centers and patients)-Global Market Trends & Industry Forecasts Upto 2023

Report code: SDMRHE6239 | Industry: Healthcare | Published On: 2/25/2018

The global bioresorbable stents market is expected to reach $ 1.6 billion by 2022 from $ 240.6 million in 2016, at a CAGR of 40.0% during the forecast period of 2018-2023. One of the major driving factors for this market is the expected growth in aging population especially those susceptible to coronary and peripheral artery diseases. Since the incidence of these diseases increases with increasing age, this is an important factor responsible for impacting the growth of this market. Over 6,00,000 thousand implants are manufactured every year and bioresorbable stents are expected to replace conventional metal stents in future. Bioresorbable stents are made of naturally dissolving polymer allowing them dissolve in body after a certain period (approximately two years) once the purpose of widening the clogged artery is served. Hence, avoiding the long term risks of restenosis and thrombosis and limiting the usage of is blood thinning medication.
Increasing focus on patient registration of bioresorbable stents is another important driver of this market. An expected 15 patients are likely to be filed in coming years. Additionally, increasing clinical trials, growing inclination of physicians and patient to encourage implementation of and high traction in minimally invasive therapy market are some of the other key factors responsible to drive the growth of this market.
However, failure of bioresorbable stents in the clinical trials to prove the theoretical advantages which they claim is a major factor that may restraint the growth of this market. Nonetheless, irrespective of this, the perceived benefits of the products yet to be launched are likely to drive the market to over $ 1.5 billion in coming years.
The market for bioresorbable stents is segmented by type of materials (polymer based and metal based), regulatory analysis (FDA, PMA and Ce), rate of absorption (Fast and Slow), type of application (Coronary artery and Peripheral artery) and end-user (Hospitals and Cardiac centers and patients). The metal stents are further classified into Iron, Magnesium, Magnesium rare earth alloys and zinc. Coating technologies, critical technology factors such as cytotoxicity and reduced corrosion rate, and technologies based on polylactide, tyrosine polycarbonate and salicylic acid pertaining to polymer based stents are discussed in details. Additionally, patents are extensively studied to give clarity to our clients for taking critical decisions.
Other key answers the study intends to provide are-
• Why hospitals segment is expected to grow at a faster rate?
• What is the impact of failure of if the clinical trials on the market growth rate?
• Which companies have a competitive edge? Will Abbot be the market leader in 2023?
• Why alloy absorption stent is expected to grow at a higher growth rate?
• Which technology is expected to grow at a faster pace and why?
• Survey on “Customer Preference on bioresorbable stents”.

Some of the major players in this market include Abbott, BIOTRONIK , Arterius Limited, Boston Scientific Corporation, ORBUSNEICH, REVA Medical, Inc., Amaranth Medical, Inc., Elixir Medical Corporation, KYOTO MEDICAL PLANNING Co., Ltd. , Arterial Remodeling Technologies, Boston Scientific Corporation, 480 Biomedical, S3V Vascular Technologies Private Limited and Qualimed.

1  Introduction                  
  1.1  Goal  &  Objective                
  1.2  Report  Coverage                
  1.3  Supply  Side  Data  Modelling  &  Methodology                
  1.4  Demand  Side  Data  Modelling  &  Methodology                
2  Executive  Summary                  
3  Market  Outlook                    
  3.1  Introduction                
  3.2  Current  &  Future  Outlook                
  3.3  DROC                
    3.3.1  Drivers              
    3.3.2  Restraints              
    3.3.3  Opportunities              
    3.3.4  Challenges              
  3.4  Market  Entry  Matrix                
  3.5  Market  Opportunity  Analysis                
  3.6  Market  Regulations                
  3.7  Pricing  Mix                
  3.8  Key  Customers                
  3.9  Value  Chain  &  Ecosystem                
4  Demand  Market  Analysis                  
  4.1  Bioresorbable  stents  Market,  By  Type                
    4.1.1  Polymer  Based             Market  Size  &  Forecasts,  2018-2023            
    4.1.2  Metal  Based               Market  Size  &  Forecasts,  2018-2023            
        Magnesium  rare  earth  alloys              
5  Bioresorbable  stents  Market,  By  Regulatory  Analysis                  
  5.1  FDA                
      Market  Size  &  Forecasts,  2018-2023              
  5.2  PMA                
      Market  Size  &  Forecasts,  2018-2023              
  5.3  Ce                
      Market  Size  &  Forecasts,  2018-2023              
  5.4  Others                
      Market  Size  &  Forecasts,  2018-2023              
6  Bioresorbable  stents  Market,  By  Rate  of  Absorption                    
  6.1  Introduction                
  6.2  Fast                
    6.2.1  Market  Size  &  Forecasts,  2018-2023              
  6.3  Slow                
    6.3.1  Market  Size  &  Forecasts,  2018-2023              
7  Bioresorbable  stents  Market,  By  Application                    
  7.1  Introduction                
  7.1  Coronary  Artery                
    7.1.1  Market  Size  &  Forecasts,  2018-2023              
  7.2  Peripheral  Artery                
    7.2.1  Market  Size  &  Forecasts,  2018-2023              
8  Bioresorbable  stents  Market,  By  End-User                  
  8.1  Introduction                
  8.2  Hospitals                
    8.2.1  Market  Size  &  Forecasts,  2018-2023              
  8.3  Cardiac  Centres                
    8.3.1  Market  Size  &  Forecasts,  2018-2023              
  8.4  Patients                
    8.4.1  Market  Size  &  Forecasts,  2018-2023              
9  Bioresorbable  stents  Market  Analysis,  By  Region                      
    9.1  North  America              
      9.1.1  U.S.            
      9.1.2  Canada            
      9.1.3  Mexico            
    9.2  Europe                
      9.2.1  Germany              
      9.2.2  Italy            
      9.2.3  France            
      9.2.4  UK            
      9.2.5  Rest  of  Europe            
    9.3  Asia  Pacific              
      9.3.1  China            
      9.3.2  Japan            
      9.3.3  India            
      9.3.4  Australia            
      9.3.5  Rest  of  APAC            
    9.4  Middle  East  &  Africa              
      9.4.1  Saudi  Arabia            
      9.4.2  UAE            
      9.4.3  Rest  Of  MEA            
    9.5  South  America              
      9.5.1  Brazil            
      9.5.2  Argentina            
      9.5.3  Rest  of  South  America            
10  Supply  Market  Analysis                  
  10.1  Strategic  Benchmarking                
  10.1  Market  Share  Analysis                
  10.1  Key  Players                  
    10.3.1  Abbott              
    10.3.2  BIOTRONIK              
    10.3.3  Arterius  Limited              
    10.3.4  Boston  Scientific  Corporation              
    10.3.5  ORBUSNEICH              
    10.3.6  REVA  Medical              
    10.3.7  Amaranth  Medical              
    10.3.8  Elixir  Medical  Corporation              
    10.3.9  KYOTO  MEDICAL  PLANNING    Co.,  Ltd.                
    10.3.10  Arterial  Remodeling  Technologies              
    10.3.11  Boston  Scientific  Corporation              
    10.3.12  Boston  Scientific  Corporation              
    10.3.13  S3V  Vascular  Technologies  Private  Limited                
    10.3.14  Qualimed  &  Others              
SDMR employs a three way data triangulation approach to arrive at market estimates. We use primary research, secondary research and data triangulation by top down and bottom up approach


Secondary Research:
Our research methodology involves in-depth desk research using various secondary sources. Data is gathered from association/government publications/databases, company websites, press releases, annual reports/presentations/sec filings, technical papers, journals, research papers, magazines, conferences, tradeshows, and blogs.

Key Data Points through secondary research-
Macro-economic data points
Import Export data
Identification of major market trends across various applications
Primary understanding of the industry for both the regions
Competitors analysis for the production capacities, key production sites, competitive landscape
Key customers
Production Capacity
Pricing Scenario
Cost Margin Analysis

Key Data Points through primary research-
Major factors driving the market and its end application markets
Comparative analysis and customer analysis
Regional presence
Collaborations or tie-ups
Annual Production, and sales
Profit Margins
Average Selling Price

Data Triangulation:
Data triangulation is done using top down and bottom approaches. However, to develop accurate market sizing estimations, both the methodologies are used to accurately arrive at the market size. Insert Image
 Feel free to contact us

Choose License Type
Select User Type

Report code